Titre : Chimiokines CX3C

Chimiokines CX3C : Questions médicales fréquentes

Termes MeSH sélectionnés :

Pilot Projects
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Chimiokines CX3C : Questions médicales les plus fréquentes", "headline": "Chimiokines CX3C : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Chimiokines CX3C : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-17", "dateModified": "2025-04-12", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Chimiokines CX3C" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Chimiokines", "url": "https://questionsmedicales.fr/mesh/D018925", "about": { "@type": "MedicalCondition", "name": "Chimiokines", "code": { "@type": "MedicalCode", "code": "D018925", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.529.374.200" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Chimiokine CX3CL1", "alternateName": "Chemokine CX3CL1", "url": "https://questionsmedicales.fr/mesh/D054428", "about": { "@type": "MedicalCondition", "name": "Chimiokine CX3CL1", "code": { "@type": "MedicalCode", "code": "D054428", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.529.374.200.130.500" } } } ], "about": { "@type": "MedicalCondition", "name": "Chimiokines CX3C", "alternateName": "Chemokines, CX3C", "code": { "@type": "MedicalCode", "code": "D020523", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Noha Mousaad Elemam", "url": "https://questionsmedicales.fr/author/Noha%20Mousaad%20Elemam", "affiliation": { "@type": "Organization", "name": "College of Medicine and Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates." } }, { "@type": "Person", "name": "Azzam A Maghazachi", "url": "https://questionsmedicales.fr/author/Azzam%20A%20Maghazachi", "affiliation": { "@type": "Organization", "name": "College of Medicine and Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates." } }, { "@type": "Person", "name": "J Robert Lane", "url": "https://questionsmedicales.fr/author/J%20Robert%20Lane", "affiliation": { "@type": "Organization", "name": "Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom." } }, { "@type": "Person", "name": "Meritxell Canals", "url": "https://questionsmedicales.fr/author/Meritxell%20Canals", "affiliation": { "@type": "Organization", "name": "Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom." } }, { "@type": "Person", "name": "Martin J Stone", "url": "https://questionsmedicales.fr/author/Martin%20J%20Stone", "affiliation": { "@type": "Organization", "name": "Monash Biomedicine Discovery Institute, and Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Service Demand for and Awareness of a Primary Healthcare Pilot Project for People With Disabilities.", "datePublished": "2022-08-01", "url": "https://questionsmedicales.fr/article/35916049", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3346/jkms.2022.37.e241" } }, { "@type": "ScholarlyArticle", "name": "[The KomMent study: a pilot project on structured interprofessional communication in uro-oncology].", "datePublished": "2022-10-07", "url": "https://questionsmedicales.fr/article/36205744", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00120-022-01945-x" } }, { "@type": "ScholarlyArticle", "name": "[Psychiatric-Psychotherapeutic Care in Crisis: Results of the LeiP#Netz Pilot Project].", "datePublished": "2022-11-25", "url": "https://questionsmedicales.fr/article/36427493", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1055/a-1902-6326" } }, { "@type": "ScholarlyArticle", "name": "Adaptation of Screening Tools for Social Determinants of Health in Pregnancy: A Pilot Project.", "datePublished": "2023-06-14", "url": "https://questionsmedicales.fr/article/37316688", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10995-023-03732-2" } }, { "@type": "ScholarlyArticle", "name": "Colorectal Cancer Screening Pilot Project in Tehran-Iran, a Feasibility Study.", "datePublished": "2023-03-01", "url": "https://questionsmedicales.fr/article/37543936", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.34172/aim.2023.22" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Facteurs biologiques", "item": "https://questionsmedicales.fr/mesh/D001685" }, { "@type": "ListItem", "position": 3, "name": "Protéines et peptides de signalisation intercellulaire", "item": "https://questionsmedicales.fr/mesh/D036341" }, { "@type": "ListItem", "position": 4, "name": "Cytokines", "item": "https://questionsmedicales.fr/mesh/D016207" }, { "@type": "ListItem", "position": 5, "name": "Chimiokines", "item": "https://questionsmedicales.fr/mesh/D018925" }, { "@type": "ListItem", "position": 6, "name": "Chimiokines CX3C", "item": "https://questionsmedicales.fr/mesh/D020523" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Chimiokines CX3C - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Chimiokines CX3C", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Chimiokines CX3C", "description": "Comment diagnostiquer une dysrégulation des chimiokines CX3C ?\nQuels marqueurs sont associés aux chimiokines CX3C ?\nLes chimiokines CX3C sont-elles mesurables dans le liquide céphalorachidien ?\nQuel rôle jouent les chimiokines CX3C dans les maladies auto-immunes ?\nPeut-on détecter les chimiokines CX3C dans les biopsies ?", "url": "https://questionsmedicales.fr/mesh/D020523?mesh_terms=Pilot+Projects&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Chimiokines CX3C", "description": "Quels symptômes sont liés à une surproduction de chimiokines CX3C ?\nLes chimiokines CX3C peuvent-elles causer des douleurs articulaires ?\nComment les chimiokines CX3C affectent-elles le système respiratoire ?\nLes chimiokines CX3C sont-elles impliquées dans les allergies ?\nQuels signes cliniques indiquent une activation des chimiokines CX3C ?", "url": "https://questionsmedicales.fr/mesh/D020523?mesh_terms=Pilot+Projects&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Chimiokines CX3C", "description": "Comment prévenir les maladies liées aux chimiokines CX3C ?\nLes vaccins influencent-ils les chimiokines CX3C ?\nY a-t-il des mesures préventives pour les maladies inflammatoires ?\nL'hygiène joue-t-elle un rôle dans la régulation des chimiokines CX3C ?\nLes compléments alimentaires peuvent-ils aider à réguler les chimiokines ?", "url": "https://questionsmedicales.fr/mesh/D020523?mesh_terms=Pilot+Projects&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Chimiokines CX3C", "description": "Quels traitements ciblent les chimiokines CX3C ?\nLes anti-inflammatoires affectent-ils les chimiokines CX3C ?\nComment les corticostéroïdes influencent-ils les chimiokines CX3C ?\nY a-t-il des traitements expérimentaux pour les chimiokines CX3C ?\nLes thérapies géniques peuvent-elles cibler les chimiokines CX3C ?", "url": "https://questionsmedicales.fr/mesh/D020523?mesh_terms=Pilot+Projects&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Chimiokines CX3C", "description": "Quelles complications peuvent survenir avec une surproduction de chimiokines CX3C ?\nLes chimiokines CX3C sont-elles liées à des cancers ?\nComment les chimiokines CX3C affectent-elles la santé cardiovasculaire ?\nLes complications neurologiques sont-elles possibles avec les chimiokines CX3C ?\nLes chimiokines CX3C peuvent-elles aggraver des infections ?", "url": "https://questionsmedicales.fr/mesh/D020523?mesh_terms=Pilot+Projects&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Chimiokines CX3C", "description": "Quels facteurs de risque sont associés aux chimiokines CX3C ?\nL'âge influence-t-il les niveaux de chimiokines CX3C ?\nLes infections antérieures augmentent-elles le risque lié aux chimiokines CX3C ?\nLe stress psychologique affecte-t-il les chimiokines CX3C ?\nLes habitudes alimentaires influencent-elles les chimiokines CX3C ?", "url": "https://questionsmedicales.fr/mesh/D020523?mesh_terms=Pilot+Projects&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysrégulation des chimiokines CX3C ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins et des analyses de cytokines peuvent aider à évaluer les niveaux de chimiokines." } }, { "@type": "Question", "name": "Quels marqueurs sont associés aux chimiokines CX3C ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les niveaux de CX3CL1 et de CX3CR1 sont souvent mesurés comme marqueurs d'inflammation." } }, { "@type": "Question", "name": "Les chimiokines CX3C sont-elles mesurables dans le liquide céphalorachidien ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les chimiokines CX3C peuvent être détectées dans le liquide céphalorachidien lors de certaines pathologies." } }, { "@type": "Question", "name": "Quel rôle jouent les chimiokines CX3C dans les maladies auto-immunes ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont souvent impliquées dans l'infiltration des cellules immunitaires dans les tissus affectés." } }, { "@type": "Question", "name": "Peut-on détecter les chimiokines CX3C dans les biopsies ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les biopsies peuvent révéler des niveaux élevés de chimiokines CX3C dans les tissus enflammés." } }, { "@type": "Question", "name": "Quels symptômes sont liés à une surproduction de chimiokines CX3C ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent inflammation, douleur, et dysfonction immunitaire dans diverses maladies." } }, { "@type": "Question", "name": "Les chimiokines CX3C peuvent-elles causer des douleurs articulaires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une surproduction peut contribuer à l'inflammation et à la douleur dans les articulations." } }, { "@type": "Question", "name": "Comment les chimiokines CX3C affectent-elles le système respiratoire ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent provoquer une inflammation des voies respiratoires, entraînant des symptômes respiratoires." } }, { "@type": "Question", "name": "Les chimiokines CX3C sont-elles impliquées dans les allergies ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent jouer un rôle dans la réponse allergique en attirant les cellules immunitaires." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une activation des chimiokines CX3C ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Rougeur, chaleur, gonflement et douleur au site d'inflammation sont des signes cliniques." } }, { "@type": "Question", "name": "Comment prévenir les maladies liées aux chimiokines CX3C ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, peut aider." } }, { "@type": "Question", "name": "Les vaccins influencent-ils les chimiokines CX3C ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains vaccins peuvent moduler la réponse des chimiokines CX3C pour une meilleure immunité." } }, { "@type": "Question", "name": "Y a-t-il des mesures préventives pour les maladies inflammatoires ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le tabac et gérer le stress peuvent réduire le risque de maladies inflammatoires." } }, { "@type": "Question", "name": "L'hygiène joue-t-elle un rôle dans la régulation des chimiokines CX3C ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une bonne hygiène peut réduire les infections et, par conséquent, l'activation des chimiokines." } }, { "@type": "Question", "name": "Les compléments alimentaires peuvent-ils aider à réguler les chimiokines ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Certains compléments, comme les oméga-3, peuvent moduler l'activité des chimiokines CX3C." } }, { "@type": "Question", "name": "Quels traitements ciblent les chimiokines CX3C ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies biologiques et des inhibiteurs de chimiokines sont utilisés pour moduler leur activité." } }, { "@type": "Question", "name": "Les anti-inflammatoires affectent-ils les chimiokines CX3C ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les anti-inflammatoires peuvent réduire la production de chimiokines CX3C dans l'inflammation." } }, { "@type": "Question", "name": "Comment les corticostéroïdes influencent-ils les chimiokines CX3C ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les corticostéroïdes diminuent l'expression des chimiokines CX3C, réduisant ainsi l'inflammation." } }, { "@type": "Question", "name": "Y a-t-il des traitements expérimentaux pour les chimiokines CX3C ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des essais cliniques explorent des inhibiteurs spécifiques des chimiokines CX3C." } }, { "@type": "Question", "name": "Les thérapies géniques peuvent-elles cibler les chimiokines CX3C ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des approches de thérapie génique sont en développement pour moduler l'expression des chimiokines." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une surproduction de chimiokines CX3C ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des maladies auto-immunes, des allergies sévères et des infections chroniques." } }, { "@type": "Question", "name": "Les chimiokines CX3C sont-elles liées à des cancers ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une dysrégulation des chimiokines CX3C peut être associée à certains types de cancers." } }, { "@type": "Question", "name": "Comment les chimiokines CX3C affectent-elles la santé cardiovasculaire ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent contribuer à l'inflammation vasculaire, augmentant le risque de maladies cardiovasculaires." } }, { "@type": "Question", "name": "Les complications neurologiques sont-elles possibles avec les chimiokines CX3C ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des niveaux élevés peuvent être impliqués dans des troubles neurologiques comme la sclérose en plaques." } }, { "@type": "Question", "name": "Les chimiokines CX3C peuvent-elles aggraver des infections ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une réponse inflammatoire excessive peut aggraver les infections et retarder la guérison." } }, { "@type": "Question", "name": "Quels facteurs de risque sont associés aux chimiokines CX3C ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'obésité, le tabagisme et le stress chronique sont des facteurs de risque connus." } }, { "@type": "Question", "name": "L'âge influence-t-il les niveaux de chimiokines CX3C ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement peut augmenter les niveaux de chimiokines CX3C, favorisant l'inflammation." } }, { "@type": "Question", "name": "Les infections antérieures augmentent-elles le risque lié aux chimiokines CX3C ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des infections passées peuvent sensibiliser le système immunitaire et augmenter les niveaux de chimiokines." } }, { "@type": "Question", "name": "Le stress psychologique affecte-t-il les chimiokines CX3C ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut augmenter la production de chimiokines CX3C, exacerbant l'inflammation." } }, { "@type": "Question", "name": "Les habitudes alimentaires influencent-elles les chimiokines CX3C ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en graisses saturées peut augmenter les niveaux de chimiokines CX3C." } } ] } ] }

Sources (10000 au total)

Service Demand for and Awareness of a Primary Healthcare Pilot Project for People With Disabilities.

This study investigated the demand for and awareness of a primary healthcare pilot project for people with disabilities; it also sought to identify relevant determinants for demand and awareness using... This study is a secondary analysis of data from the population-based survey conducted in Gyeonggi Regional Health & Medical Center for People with Disabilities. The data was designed with quota ra... Awareness of the service (12.1%) was remarkably low, while the demand (80.5%) was high. The gap between respondents who needed the service but were unaware of it differed according to age, education, ... Chronic disease and an unmet need for medical care were key determinants of service demand, while the severity of disability was not. Thus, there is a need to review the initiative that defines servic...

[The KomMent study: a pilot project on structured interprofessional communication in uro-oncology].

Communication and interprofessional collaboration with patients diagnosed with cancer is challenging. Structured communication training has not yet been integrated into postgraduate medical education.... A needs assessment was conducted using focus groups and individual interviews. Learning objectives were aligned with (inter)national learning objective catalogs. The ICT was developed using the six-st... Physician participation rates in the workshops were 83.0% and nursing participation rates were 58.3%. Utilization of the workplace-based training was 97%. The physicians evaluated the ICT very positiv... The implementation of an ICT with 80 teaching units is successfully feasible in a urological clinic and leads to a sustainable improvement of the communication culture, among other things through ment...

[Psychiatric-Psychotherapeutic Care in Crisis: Results of the LeiP#Netz Pilot Project].

Analysis of psychiatric-psychotherapeutic crisis services in the Leipzig Psychiatry Network (LeiP#netz), assigning the services to the functional areas of the FBM according to Steinhart and Wienberg.... A standardized survey of crisis care was conducted using the functions "complex outpatient treatment", "access to acute psychotherapy in crisis", and "24 h complex, intensive treatment" by means of fa... A total of 31 measures were recorded for the three functions. All crisis care services were highly utilized; in up to one-third of cases, no services could be provided when demand was requested. Servi... Crisis care services for severely mentally ill people are available in various constellations in the study region. Low-threshold 24/7 crisis services need to be expanded....

Adaptation of Screening Tools for Social Determinants of Health in Pregnancy: A Pilot Project.

Social determinants of health (SDOH) and stress during pregnancy may contribute to adverse pregnancy outcomes. The objective of this in the field pilot project was to develop a comprehensive screening... Pregnant patients accessing prenatal care at a single site of an urban Federally Qualified Health Center were recruited during prenatal visits to complete a Social Determinants of Health in Pregnancy ... Between April 2018 and March 2019, 135 pregnant participants completed SIPT. Ninety-one percent of patients scored positive on at least one screener, 54% to three or more screeners.... Despite guidelines to screen for SDOH during pregnancy there is no universal tool. Our pilot project demonstrated the concurrent use of adapted screening tools where participants reported at least one...

Colorectal Cancer Screening Pilot Project in Tehran-Iran, a Feasibility Study.

Colorectal cancer (CRC) is the third most common cancer in Iran, where there is no organised CRC-screening programme. This study aimed to evaluate feasibility of CRC screening using a qualitative feca... In this feasibility study, 7039 individuals aged 50-75 years were invited by community health workers (CHWs) in southern Tehran and its suburban districts between April 2018 and November 2019. The CHW... Acceptance rate at initial invitation was 71.7%. From 4974 average-risk adults (1600 males and 3374 females) who were offered FIT, 96.8% (n=4813) provided valid samples, of whom 471 (9.8%) tested posi... Our results partially support the feasibility of scaling up organized CRC-screening through the existing healthcare system in Iran; it remains to be discussed carefully to ensure the capacity of healt...

Conducting two evidence syntheses in six weeks - experiences with and evaluation of a pilot project.

Evidence synthesis organisations are trying to meet commissioners' needs for rapid responses to their evidence synthesis commissions. In this project we piloted an intensive process, working to comple... In a pre-planning phase, an intensive work group was established, and two commissions were selected for this pilot project. The evidence synthesis process was divided into two phases: planning and int... During the planning phase, teams identified significant uncertainties regarding scopes, research questions, and inclusion criteria. To address this, they engaged with commissioners earlier than origin... Overall, the intensive process fostered focus and productivity, allowing teams to manage short-term deliverables effectively. The researchers preferred working intensively with one evidence synthesis ...

[Implementation of a Pilot Project Supporting Parents Suffering from Cancer with Underage Children].

Families with one parent suffering from cancer are exposed to extraordinary emotional and organizational burdens, affecting underaged children. To help coordinated access to social and logistic suppor... A cross-sectional observational study was conducted using a mixed-method approach. Semi-structured written expert surveys (n=10) and secondary analysis of routine data of the care model (n=171 familie... Quantitative secondary analysis: The participating families had 1-7 children (median (m) 2, range (s) 6). In 66% of the cases, the mother was affected by cancer, in 20% the diseased parent was in a si... The data collected indicate that in families, matching the German average in their socio-demographic characteristics, a great need for organizational support develops as soon as one parent becomes sic...

A pilot project of expert nurses for the follow-up of complex intravenous antimicrobial treatment.

To report a pilot project of expert nurses for outpatient parenteral antimicrobial treatment (OPAT) follow-up.... Three nurses with specific training on antibiotics started a state-funded programme including: i) consultations for OPAT follow-up; ii) hotline for satellite hospitals; iii) peer training. Patients' d... From December 2020 to December 2021, 118 patients (median age 66.5 years [52-75], male-to-female ratio 2.5) were enrolled, for a total of 621 consultations. Patients were mostly on OPAT for bone and j... Nurses may be important actors for OPAT follow-up....

Implementation of entrustable professional activities into fellowship council accredited programs: a pilot project.

The Fellowship Council (FC) is transitioning to a competency-based medical education (CBME) model, including the introduction of Entrustable Professional Activities (EPAs) for training and assessment ... The FC coordinated the development of EPAs in collaboration with the sponsoring societies for Advanced GI/MIS, Bariatrics, Foregut, Endoscopy and Hepatopancreaticobiliary (HPB) fellowships encompassin... The 15 participating programs included 18 fellows and 106 faculty. A total of 655 assessments were initiated with 429 (65%) completed. The average (SD) number of EPAs completed for each fellow was 24(... A competency-based assessment framework was developed by the FC and piloted in several programs. Participation was variable and required ongoing strategies to address barriers. The pilot project has p...